Drug Profile
DPR
Alternative Names: Cis-diamminedichloroplatinum (II)Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer